Topical Iodine–Induced Thyrotoxicosis in a Newborn with a Giant Omphalocele

Abstract

Introduction Neonatal thyrotoxicosis is a life-threatening condition with potentially irreversible neurologic sequelae. Most cases are seen in neonates born to mothers with Graves' disease. Topical iodine–induced hypothyroidism has been reported in neonates, but iodine–induced neonatal hyperthyroidism has not been described; albeit a familiar entity in adults.

Case Description Herein we present a unique case of a neonate, born with a giant omphalocele, who was treated with topical povidone-iodine dressings to promote escharification, in preparation for delayed surgical closure. By third day of life (DOL), the baby presented with a suppressed thyroid stimulating hormone of 0.59 µIU/mL, elevated free thyroxine of 5.63 ng/dL, and frank cardiovascular manifestations of thyrotoxicosis. After replacement of the topical iodine dressings with iodine-free silver sulfadiazine, the thyroid status gradually improved with complete resolution of hyperthyroidism by 17th DOL.

Conclusion This case emphasizes that significant topical iodine exposure can result in both hypothyroidism and hyperthyroidism, and therefore, vigilance in monitoring thyroid function is imperative.

Keywords

neonate - thyrotoxicosis - topical povidone-iodine - giant omphalocele

• References

• 1 Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999; 9 (7) 727-733
• 2 Aslam M, Inayat M. Fetal and neonatal Graves disease: a case report and review of the literature. South Med J 2008; 101 (8) 840-841
• 3 Batra CM. Fetal and neonatal thyrotoxicosis. Indian J Endocrinol Metab 2013; 17 (1) (Suppl. 01) S50-S54
• 4 Thomas JS, Leclere J, Hartemann P , et al. Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh) 1982; 100 (4) 512-518
• 5 Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 2002; 87 (3) F165-F171
• 6 Whitehouse JS, Gourlay DM, Masonbrink AR , et al. Conservative management of giant omphalocele with topical povidone-iodine and its effect on thyroid function. J Pediatr Surg 2010; 45 (6) 1192-1197
• 7 Cosman BC, Schullinger JN, Bell JJ, Regan JA. Hypothyroidism caused by topical povidone-iodine in a newborn with omphalocele. J Pediatr Surg 1988; 23 (4) 356-358
• 8 Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 1948; 174 (2) 555-564
• 9 El-Shirbiny AM, Stavrou SS, Dnistrian A, Sonenberg M, Larson SM, Divgi CR. Jod-Basedow syndrome following oral iodine and radioiodinated-antibody administration. J Nucl Med 1997; 38 (11) 1816-1817
• 10 Shetty KR, Duthie Jr EH. Thyrotoxicosis induced by topical iodine application. Arch Intern Med 1990; 150 (11) 2400-2401
• 11 Rajatanavin R, Safran M, Stoller WA, Mordes JP, Braverman LE. Five patients with iodine-induced hyperthyroidism. Am J Med 1984; 77 (2) 378-384
• 12 Rath T, Meissl G. Induction of hyperthyroidism in burn patients treated topically with povidone-iodine. Burns 1988; 14 (4) 320-322